Course Outcomes (COs):
Course Outcomes |
Learning and teaching strategies |
Assessment Strategies |
|
On completion of this course the learner will: CO 70: Analyze the different aspects of host-microbe interactions will identify the role of resident flora in maintaining health and different types of virulence factors involved in establishing pathogenesis. CO 71: Evaluate the pathogenesis of bacterial diseases and identify the laboratory-based methods for their identification. CO 72: Understand the life cycle of pathogenic viruses, identify the methods for their diagnosis treatment and prophylaxis. CO 73: Understand the life cycle of protozoans that cause human infections, identify the symptoms of the diseases, treatment and prophylaxis strategies. CO 74: Diagnose common infectious diseases from the clinical presentation and describe the epidemiology of infectious agents. CO 75: Differentiate, compare and contrast the mode of action of antibiotics, antifungal and antiviral agents and their resistance mechanisms. |
Interactive Lectures, Discussion, Tutorials, Demonstrations, Assignments Reading Journals |
Class test, Semester end examinations, Quiz, Solving problems in tutorials, Assignments, Presentation |
Normal microbial flora of human body and its role, Opportunistic flora.
Pathogenesis, pathogenicity and virulence; Quantitative measures of virulence: minimal lethal dose (MLD), LD50, ID50, TCID50. Entry of pathogens into the host; colonization and mechanism of bacterial adhesion, establishment, virulence factors, exotoxins, endotoxins, their structure and mode of action.
Biosafety levels and Guidelines
Etiology, Pathogenicity, Epidemiology, Lab diagnosis, treatment and prevention of diseases caused by:
Pyogenic cocci- Staphylococci, Streptococci, Neisseria meningitides, N. gonococcus
Gram positive cocci- Clostridium tetani
Mycobacteria- M. tuberculosis, M. leprae
Etiology, Pathogenicity, Epidemiology, Lab diagnosis, treatment and prevention of diseases caused by
Enteric Gram negative bacteria- Salmonella, Shigella, Vibrio cholera, E. coli
Spirochaetes- Treponema palladium
Chlamydiae- Trachoma, Rickettesial diseases, Diseases caused by Mycoplasma,
Pathogenic fungi- Candida albicans
Protozoan diseases – Malaria, Amoebiasis
Animal viruses Epidemiology, life cycle, pathogenicity, diagnosis, prevention and treatment of RNA viruses- Picorna viruses - Poliomyelitis, Orthomyxoviruses- influenza, Paramyxoviruses- Mumps, Measles, retroviruses-HIV; DNA viruses; Pox virus- Variola and Vaccina, Herpes virus- Varicella Zoster virus, Hepatitis viruses, Arthropod borne (arbo) Viral disease- Dengu, SARS CoV-2
Antibiotics: Mode of action and resistance mechanisms of β-lactams, glycopeptides, bacitracin, Polymyxins, aminoglycosides, tetracyclines, macrolides, chloramphenicol, quinolones, Sulfa drugs and trimethoprim, Antifungal and antiviral drugs. Methods of drug susceptibility testing. Toxicological evaluation of drug (LD50, Acute, subacute and chronic toxicity), Mutagenicity (Ames test, micronucleus test) and Carcinogenicity. Phase I -IV of clinical trials of drugs.
SUGGESTED READINGS:
e RESOURCES:
JOURNALS: